methylprednisolone acetate has been researched along with Sclera Diseases in 1 studies
Methylprednisolone Acetate: Methylprednisolone derivative that is used as an anti-inflammatory agent for the treatment of ALLERGY and ALLERGIC RHINITIS; ASTHMA; and BURSITIS; and for the treatment of ADRENAL INSUFFICIENCY.
methylprednisolone acetate : An acetate ester resulting from the formal condensation of the 21-hydroxy function of 6alpha-methylprednisolone compound with acetic acid.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| COLES, RS | 1 |
| KROHN, DL | 1 |
| BRESLIN, H | 1 |
| BRAUNSTEIN, R | 1 |
1 other study available for methylprednisolone acetate and Sclera Diseases
| Article | Year |
|---|---|
Depo-Medrol in treatment of inflammatory diseases.
Topics: Glaucoma; Humans; Keratitis; Methylprednisolone; Methylprednisolone Acetate; Prednisolone; Sclera; S | 1962 |